ArticleAnnals of internal medicine2024

Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.

Anirban Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.